CARLEN is a novel native leaflet augmenting implant that is deployed onto a leaflet of the mitral or tricuspid valve, using a transfemoral delivery catheter. The augmented native leaflet increases the surface of coaptation for the valve and eliminates regurgitation. In few weeks, the CARLEN implant is engulfed in an endothelialized layer of tissue, providing a focally enhanced native leaflet that suits the patients valve geometry, addressing a large patient population.
|
Nyra Medical CARLEN is an investigational device only and not available for sale in any geography
|
|